Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

Anticipated products to emanate from Professor Jocelyn Faubert's lab

Cutting-edge technologies are about to enter the marketplace, thanks to a new partnership between Gestion Univalor, Limited Partnership (Univalor) and Cognitive Sensing Inc. (CSI), a privately owned technology company based in Montreal.

Univalor, which commercializes discoveries from the Universit- de Montr-al and its affiliated institutions, and CSI have announced the signature of a license agreement giving CSI exclusive worldwide rights to develop, manufacture and market four scientifically proven products developed by Jocelyn Faubert, a professor at the Universit- de Montr-al School of Optometry and CSI's chief science officer.

Among the most anticipated products to emanate from Professor Faubert's lab is a portable sports simulator that allows athletes to improve their game and reaction time. Another technology opens doors to the early detection, measurement and treatment of concussions and conditions such as Alzheimer's and autism.

"We are impressed by the quality of the research generated by Prof. Jocelyn Faubert and his team. Technologies created in his lab present exciting market opportunities in the medical, sports and rejuvenation markets," says Jean Castonguay, chief executive officer of CSI and a seasoned entrepreneur. "CSI has already entered into agreements with Industry leaders to validate the first applications of these technologies".

Adds Marc Leroux, CEO of Univalor: "We are delighted to associate these Universit- de Montr-al technologies with CSI and their experienced management team. We look forward to a lasting relationship."

Patented technologies:

Scientific validation of Prof. Faubert's technologies was established in numerous peer-reviewed journals such as Brain and Psychological Science. His creations are currently being tested at several centers; the first are set for commercial validation in January 2010. Under the licensing agreement, CSI will provide financial support for patent protection in various territories in addition to other payments. The patented technologies include:

• MPI (Mild Perceptual Impairment Device): An apparatus to diagnose and monitor brain trauma, concussions, Alzheimer's disease and other neurobiological conditions.
• 3D-MOT (3D Multiple Object Tracking): A device to enhance sports performance, as well as assess, train and improve perception in people of all ages.
• MSRS (Multisensory Stochastic Resonance Stimulation): A technology to improve sense and balance via auditory and visual stimulation.
• Noisy Bits: Software to improve image quality in standard displays and projectors by generating continuous luminance.